Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/97184
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Pardo, Yolanda |
dc.contributor.author | Guedea Edo, Ferran |
dc.contributor.author | Aguiló Lúcia, Fernando |
dc.contributor.author | Fernández, Pablo |
dc.contributor.author | Macías, Víctor |
dc.contributor.author | Mariño, Alfonso |
dc.contributor.author | Hervás, Asunción |
dc.contributor.author | Herruzo, Ismael |
dc.contributor.author | Ortiz, María José |
dc.contributor.author | Ponce de León, Javier |
dc.contributor.author | Craven-Bartle, Jordi |
dc.contributor.author | Suárez, José Francisco |
dc.contributor.author | Boladeras, Ana |
dc.contributor.author | Pont, Àngels |
dc.contributor.author | Ayala Gil, Adriana |
dc.contributor.author | Sancho, Gemma |
dc.contributor.author | Martínez, Evelyn |
dc.contributor.author | Alonso, Jordi |
dc.contributor.author | Ferrer, Montserrat |
dc.date | 2016-04-08T07:25:48Z |
dc.date | 2016-04-08T07:25:48Z |
dc.date | 2010-10-04 |
dc.date | 2016-04-08T07:25:53Z |
dc.identifier.citation | 0732-183X |
dc.identifier.citation | 620187 |
dc.identifier.uri | http://hdl.handle.net/2445/97184 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1200/JCO.2009.25.3245 |
dc.relation | Journal of Clinical Oncology, 2010, vol. 28, num. 31, p. 4687-4696 |
dc.relation | http://dx.doi.org/10.1200/JCO.2009.25.3245 |
dc.rights | (c) American Society of Clinical Oncology, 2010 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Càncer de pròstata |
dc.subject | Qualitat de vida |
dc.subject | Hormonoteràpia |
dc.subject | Prostatectomia |
dc.subject | Radioteràpia |
dc.subject | Prostate cancer |
dc.subject | Quality of life |
dc.subject | Hormone therapy |
dc.subject | Prostatectomy |
dc.subject | Radiotherapy |
dc.title | Quality of life impact of primary treatments for localized prostate cancer patients without hormonal treatment |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |